Children’s Lives DON’T Matter –

May 25, 2018 – In April, a committee at the Food and Drug Administration took the unprecedented step to recommend for approval Epidiolex, an epilepsy drug containing a plant-sourced cannabinoid, cannabidiol (CBD). In June, the FDA will vote on approving the drug, which has been shown in limited studies to be effective for those suffering from severe epilepsy. Maria Selva’s seven-year-old daughter, Aliana, has epilepsy and has found relief from seizures with CBD … But treating her daughter’s seizures with CBD has put Selva at significant risk, and she has mixed feelings about the FDA’s potential approval of Epidiolex. In October 2017, Child Protective Services charged Maria and her husband with “severe medical neglect,” and removed Aliana from her parents’ care.

Full Story @ TheDailyBeast.com